Virax Biolabs Files 6-K Report
Ticker: VRAX · Form: 6-K · Filed: Mar 13, 2025 · CIK: 1885827
| Field | Detail |
|---|---|
| Company | Virax Biolabs Group Ltd (VRAX) |
| Form Type | 6-K |
| Filed Date | Mar 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, routine-report
TL;DR
Virax Biolabs filed a 6-K on 3/13/25, standard reporting.
AI Summary
Virax Biolabs Group Ltd. filed a Form 6-K on March 13, 2025, to report information for the month of March 2025. The filing indicates the company's principal executive offices are located at BioCity Glasgow, Bo'Ness Road, Newhouse, Lanarkshire, ML1 5UH, United Kingdom. Virax Biolabs Group Limited is registered with the SEC under file number 001-41440.
Why It Matters
This filing provides routine updates and information for investors regarding Virax Biolabs Group Ltd.'s operational status and reporting requirements.
Risk Assessment
Risk Level: low — This is a routine 6-K filing, which typically contains standard corporate information and does not indicate significant new risks.
Key Players & Entities
- Virax Biolabs Group Ltd. (company) — Registrant
- 001-41440 (company) — SEC File Number
- March 13, 2025 (date) — Filing Date
- BioCity Glasgow (company) — Business Address Location
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, typically providing information that the company makes or is required to make public in its home country.
What is the SEC file number for Virax Biolabs Group Ltd.?
The SEC file number for Virax Biolabs Group Ltd. is 001-41440.
Where are Virax Biolabs Group Ltd.'s principal executive offices located?
The principal executive offices of Virax Biolabs Group Ltd. are located at BioCity Glasgow, Bo'Ness Road, Newhouse, Lanarkshire, ML1 5UH, United Kingdom.
What is the SIC code for Virax Biolabs Group Ltd.?
The Standard Industrial Classification (SIC) code for Virax Biolabs Group Ltd. is 2835, which pertains to 'IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES'.
Does Virax Biolabs Group Ltd. file annual reports under Form 20-F or 40-F?
Virax Biolabs Group Ltd. indicates it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 13, 2025 regarding Virax Biolabs Group Ltd (VRAX).